Near-Patient Molecular Solutions Market – Latest Research, Industry Analysis, Driver, Trends, Business Overview, Key Value, Demand And Forecast 2022 to 2032

 Throughout the projected period, the near-patient molecular solutions market is anticipated to grow at an impressive CAGR of 8%. By 2033, the market is expected to be worth US$ 7.56 billion, up from US$ 3.5 billion in 2023, according to FMI.

Point of care testing has extensive application base that includes, oncology, hematology, endocrinology, prenatal testing and near patient testing in infectious disease management. Most substantial progress have taken place in the fields of oncology point of care molecular tests and infectious diseases.Rapid flu testing is a leading application for point of care platforms.

Near-Patient Molecular Solutions Market: Drivers and Restraints

Factors, such as the increasing incidences of diseases such as cardiac diseases and diabetes in developing countries, increase in the usage of home-based point of care devices, and advancement in technology with demand for development of faster and easy to use devices are energizing the point of care diagnostic market.

For more insights into the market, request a sample of this report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-2098 

Rising demand for home healthcare facility and the increment in population of elderly patients with multiple chronic conditions is expected to drive point of care diagnostics market over the forecast period. In light of the many factors increasing the demand for point of care diagnosis, manufacturing companies are pushing the envelope to make point of care devices faster, easier, and more reliable. Shortage of skilled-staff, especially in the field of diagnostics, are expected to restrain the market growth for point of care diagnostic.

Near-Patient Molecular Solutions Market: Overview

Although the market of near patient diagnostic is less, but it is expected to grow over forecast period according to new healthcare analysis. It has been observed that near patient molecular solutions have witnessed higher penetration in medical system market though they facilitate better antimicrobial treatment.

Point of care products for diagnosis of tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis, malaria and other infectious diseases are supposed to achieve substantial growth in emerging markets. Manycompanies are developing molecular diagnostic platforms and assays that are designed to for near-patient. The initial focus of most of the medical devices companies is on infectious disease testing.

Near-Patient Molecular Solutions Market: Regional Overview

Region wise, the global near patient molecular solution market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for near patient molecular solution due to good reimbursement policies for diagnostic procedures and number of clinical studies investigating the efficiency.

After North America this market is followed by Europe due to increase demand for near patient testing growth over. Asia Pacific region is expected to perceive a significantly faster growth over the forecast period due to a lower availability of hi-tech central laboratory testing facilities.Increasing number of local players providing near patient testing in countries such as China is expected to boost the market growth in APEJ region.

Near-Patient Molecular Solutions Market: Key Players

Some of the key players in the market of near patient molecular solution are Abbott Laboratories, Inc. Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., PTS Diagnostics and Nova Biomedical. Other prominent player in near patient molecular solution market are Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Cepheid, Danaher Corporation.

For Information On The Research Approach Used In The Report, Ask Analyst @
 https://www.futuremarketinsights.com/askus/rep-gb-2098 

The report covers exhaustive analysis on

·         Market Segments

·         Market Dynamics

·         Market Size

·         Supply & Demand

·         Current Trends/Issues/Challenges

·         Competition & Companies involved

·         Technology

·         Value Chain

Full Report @ https://www.futuremarketinsights.com/reports/near-patient-molecular-solutions-market

Comments

Post a Comment

Popular posts from this blog

Cardboard Flask Market Insights By Type, Industry, Application & End-User | FMI

 Beverage industry which is growing continuously has led to developments and innovations in the cardboard flask market. Countries that have high consumption of tea and coffee such as the USA, United Kingdom, China, Japan & India might impact the demand for cardboard flask. Cardboard flasks might not be predominant when it comes to the sale of these hot beverages in the brick and mortar store but E-commerce has hiked the demand for cardboard flask. The convenience and ease of ordering the hot beverages at their workplace and homes with advent of digitalization in developing countries such as India and China is likely to augment the demand for the cardboard flask market. Compared to its counterpart which is a traditional flask which were used by the brand owners to deliver the beverage to its customers, the cardboard flask provides more pros since its cuts down the cost of collecting and cleaning them. Thus, this is likely to positively impact the growth of the cardboard flask ma...
Read more

Radiopharmaceuticals Market: Worldwide Industry Analysis and New Market Opportunities Explored to 2032

  As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases,  radiopharmaceutical market  registered steady year-on-year growth Future Market Insights (FMI) predicted that the market for radiopharmaceuticals would be valued US$ 6.2 billion in 2022. The market for radiopharmaceuticals is expected to grow at a value CAGR of 4.3% between 2022 and 2032, reaching US$ 9.5 billion. Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over  4.66% CAGR  during the forecast period of 2021 and 2031. Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Te...
Read more

Voice Assistants Market Research Report 2022 – Global Forecast till 2032

 The rising popularity of smartphones coupled with the increasing demand for sophisticated assistive technology will assure considerable growth opportunities for the voice assistant market during the forecast period of 2022-2032. The market for voice assistants is predicted to expand at a CAGR of 19% and reach US$ 4,329.0 million in 2022. By 2032, it is anticipated that the market would grow to US$ 24,588 Million. In addition, the rise in activities such as data collection through mobile devices, unified communications, and wireless network strengthens the growth trajectory to a considerable extent. Recent Development Automating repetitive tasks is an important benefit offered by voice assistant applications. While routine tasks are carried out by voice assistant applications, humans can perform other tasks that are more important. Thus, introducing voice assistants not only enhances consumer experience but also increases the productivity levels of an organization or a business. Th...
Read more